QuidelOrtho Adds Fentanyl Test To Its Vitros Systems As A MicroTip Partnership Assay To Help Hospital And Emergency Room Customers Allow On-site Fentanyl Testing In Less Than 10 Minutes
Portfolio Pulse from Benzinga Newsdesk
QuidelOrtho has introduced a fentanyl test for its Vitros Systems, developed through a MicroTip Partnership, enabling hospitals and emergency rooms to conduct on-site fentanyl testing in under 10 minutes. This addition aims to enhance patient care by providing rapid results, potentially increasing the demand for Vitros Systems.
April 10, 2024 | 11:09 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
QuidelOrtho's introduction of a fentanyl test for Vitros Systems could see increased demand for these systems in hospitals and emergency rooms, potentially boosting QDEL's revenue and market position.
The introduction of a rapid fentanyl test directly aligns with QuidelOrtho's product line and market strategy, enhancing its Vitros Systems' value proposition. This innovation is likely to be well-received by hospitals and emergency rooms, driving up demand for Vitros Systems. Given the opioid crisis and the need for rapid testing solutions, this addition could significantly impact QDEL's revenue and strengthen its position in the healthcare diagnostics market.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90